Considerations in polypharmacy and high-risk medications contributing to inpatient falls in geriatric patients

被引：0
|
作者：
Matthews, M. [1 ]
Gurvich, T. [1 ]
Al Eid, K. [2 ]
Gibbs, L. M. [3 ]
机构：
[1] Univ Southern Calif, Pharm, Los Angeles, CA 90007 USA
[2] Univ Calif Irvine, Nursing, Irvine, CA USA
[3] Univ Calif Irvine, Geriatr, Irvine, CA USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2020年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
D196
引用
收藏
页码：S292 / S292
页数：1
相关论文
共 50 条
  • [31] Co-morbidities and polypharmacy in high-risk patients with type 2 diabetes mellitus
    Nwachuku, U
    Woods, KF
    Schlundt, DG
    Hargreaves, MK
    McNeil, L
    Nwokoro, U
    Adeola, T
    Self, I
    DIABETES, 2001, 50 : A499 - A499
  • [32] Changes in medicine prescription following a medication review in older high-risk patients with polypharmacy
    Hurmuz, Marian Z. M.
    Janus, Sarah I. M.
    van Manen, Jeannette G.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (02) : 480 - 487
  • [33] Medications Associated with Geriatric Syndromes and Prescribing Patterns: The Impact of Excessive Polypharmacy in Older Adult Patients
    Al-Azayzih, Ahmad
    Al-Qerem, Walid
    Al-Azzam, Sayer
    Alzoubi, Karem H.
    Jirjees, Feras
    Al-Kubaisi, Khalid
    Kharaba, Zelal
    Muflih, Suhaib
    Kanaan, Roaa J.
    Abandeh, Ayah H.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2024, 20 : 741 - 748
  • [34] Development of High-Risk Geriatric Polypharmacy Electronic Clinical Quality Measures and a Pilot Test of EHR Nudges Based on These Measures
    Persell, Stephen D.
    Brown, Tiffany
    Doctor, Jason N.
    Fox, Craig R.
    Goldstein, Noah J.
    Handler, Steven M.
    Hanlon, Joseph T.
    Lee, Ji Young
    Linder, Jeffrey A.
    Meeker, Daniella
    Rowe, Theresa A.
    Sullivan, Mark D.
    Friedberg, Mark W.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (11) : 2777 - 2785
  • [35] Changes in medicine prescription following a medication review in older high-risk patients with polypharmacy
    Marian Z. M. Hurmuz
    Sarah I. M. Janus
    Jeannette G. van Manen
    International Journal of Clinical Pharmacy, 2018, 40 : 480 - 487
  • [36] Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting - Reply
    Zarowitz, Barbara J.
    PHARMACOTHERAPY, 2006, 26 (06): : 887 - 887
  • [37] Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults
    Richardson, Kathryn
    Bennett, Kathleen
    Kenny, Rose Anne
    AGE AND AGEING, 2015, 44 (01) : 90 - 96
  • [38] Development of High-Risk Geriatric Polypharmacy Electronic Clinical Quality Measures and a Pilot Test of EHR Nudges Based on These Measures
    Stephen D. Persell
    Tiffany Brown
    Jason N. Doctor
    Craig R. Fox
    Noah J. Goldstein
    Steven M. Handler
    Joseph T Hanlon
    Ji Young Lee
    Jeffrey A. Linder
    Daniella Meeker
    Theresa A Rowe
    Mark D. Sullivan
    Mark W. Friedberg
    Journal of General Internal Medicine, 2022, 37 : 2777 - 2785
  • [39] Impact of Comorbidities on the Risk of Polypharmacy and Potentially Inappropriate Medications in Older Patients
    Hamada, Shota
    Iwagami, Masao
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (SUPPL 1) : 53 - 59
  • [40] Impact of Comorbidities on the Risk of Polypharmacy and Potentially Inappropriate Medications in Older Patients
    Sheu, Kai- Lun
    Chen, Chun-Chieh
    Chen, Shiuan-Chih
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (07) : 1270 - 1271
12345